Domain Holdings Australia (ASX: DHG) has kicked off the year with an impressive first-half performance, reporting a 7% increase in revenue to $217.2 million and a 28% jump in net…
BHP Announces Chair Succession: Ross McEwan to Take the Helm in 2025
BHP (ASX: BHP) has confirmed that its Chair, Ken MacKenzie, will retire from the Board on March 31, 2025, bringing an end to nearly a decade of leadership at the…
Suncorp Delivers Strong 1H25 Results, Announces Capital Return to Shareholders
Suncorp Group (ASX: SUN) has kicked off 2025 with a bang, reporting a $1.1 billion net profit after tax (NPAT) for the first half of the financial year—an 89% jump…
St Barbara to Separate Atlantic Gold Operations
St Barbara Limited (ASX: SBM) has announced its intention to separate its Atlantic Gold Operations in Nova Scotia, Canada. The move follows a detailed portfolio review, concluding that a standalone…
Evolution Mining Delivers Record Profit and Cash Flow in FY25 H1, Boosting Dividend by 250%
Evolution Mining Limited (ASX: EVN) has delivered a stellar first half for FY25, reporting a record statutory net profit of $365 million for the six months ending 31 December 2024….
CBA Delivers Solid 1H25 Results Amid Economic Challenges
Commonwealth Bank of Australia (ASX: CBA) has reported a strong financial performance for the first half of FY25, despite ongoing economic headwinds. The bank’s results highlight its disciplined approach to…
AGL Energy Announces Strong 1H25 Results and Provides Updated FY25 Guidance
AGL Energy Limited (AGL) today reported its financial results for the six months ending 31 December 2024 (1H25). Key Financial Highlights: Updated FY25 Guidance: CEO Commentary on 1H25 Performance: AGL’s…
SGH Delivers Strong First-Half Growth, Boosts Dividend by 30%
SGH Ltd (ASX:SGH) has kicked off FY25 with a bang, delivering double-digit earnings growth and rewarding shareholders with a 30% boost to its interim dividend. Despite mixed market conditions, the…
Clarity Pharmaceuticals Expands Breast Cancer Pipeline with Cu-64/67 SAR-trastuzumab
Clarity Pharmaceuticals is ramping up its efforts in the breast cancer treatment space with the addition of 64/67Cu-SAR-trastuzumab to its Targeted Copper Theranostic (TCT) portfolio. The company recently published pre-clinical…
Macquarie Group 3Q 2025 Trading Update
Macquarie Group recently shared an update on its financial performance for the nine months ending December 31, 2024, and overall, the results are in line with what was seen in…